Keel Paul A
Transaction: 05/25/2026
SELL
Change
-12,811
Price
$23.43
Filing
05/27/2026
Type
SELL
Envista Holdings Corp
NVST • Medical - Instruments & Supplies
$27.28
▼ -0.31 (-1.12%)
Current price
EarningsLatest report: Jul 3, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$4.46B
Growth
-1.2%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 1.37Consistent free cash flow · 5/5Manageable debt level · 0.55Healthy liquidity · 2.38Expensive earnings multiple · 77.6
Financial data as of: Jul 3, 2026, 12:00 AM UTCLast earnings update: Jul 3, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:44 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$27.28
Change-1.12%
Market Cap$4.46B
52W Range18.77 - 30.42
Beta0.86
Gross Margin55.02%
Oper. Margin8.30%
Profit Margin1.73%
Debt/Eq0.55
Current Ratio2.38
Quick Ratio2.04
Revenue 5Y-1.18%
Price$27.28
Change-1.12%
Market Cap$4.46B
52W Range18.77 - 30.42
Beta0.86
Gross Margin55.02%
Oper. Margin8.30%
Profit Margin1.73%
Debt/Eq0.55
Current Ratio2.38
Quick Ratio2.04
Revenue 5Y-1.18%
FCF 5Y-5.94%
Target$29.14
Target Upside6.82%
Target Median$29.00
Target Range23.00 - 34.00
Volume5.47M
Avg Volume3.10M
EPS Surprise0.05
Investment DNA
How strong this company looks for long-term investors
59
out of 100
Business Quality
Margins, moat, returns
40/100
Financial Strength
Debt, cash, stability
86/100
Growth Potential
Revenue and expansion
25/100
Price Attractiveness
Cheap or expensive today
73/100
Why this score▼
Positive free cash flow · 1.37Consistent free cash flow · 5/5Manageable debt level · 0.55Healthy liquidity · 2.38Expensive earnings multiple · 77.6Negative growth trend
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$23.00
Mean
$29.14
Median
$29.00
High
$34.00
Insider Transactions
Recent executive and insider activity
Huennekens R Scott
Transaction: 05/19/2026
BUY
Change
+12,585
Price
Not reported
Filing
05/21/2026
Type
BUY
Raskas Daniel
Transaction: 05/19/2026
BUY
Change
+9,330
Price
Not reported
Filing
05/21/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Keel Paul A | SELL | -12,811 | $23.43 | 05/25/2026 | 05/27/2026 |
| Huennekens R Scott | BUY | +12,585 | Not reported | 05/19/2026 | 05/21/2026 |
| Raskas Daniel | BUY | +9,330 | Not reported | 05/19/2026 | 05/21/2026 |
| Pierce James Andrew | BUY | +9,330 | Not reported | 05/19/2026 | 05/21/2026 |
| GALLAHUE KIERAN | BUY | +9,330 | Not reported | 05/19/2026 | 05/21/2026 |
| Jain Vivek | BUY | +9,330 | Not reported | 05/19/2026 | 05/21/2026 |
| TSINGOS CHRISTINE A | BUY | +9,330 | Not reported | 05/19/2026 | 05/21/2026 |
| Carruthers Wendy | BUY | +9,330 | Not reported | 05/19/2026 | 05/21/2026 |
| Befidi Robert | BUY | +13,845 | Not reported | 02/25/2026 | 02/27/2026 |
| Befidi Robert | BUY | +18,020 | $29.59 | 02/25/2026 | 02/27/2026 |
| Befidi Robert | SELL | -2,177 | $29.59 | 02/25/2026 | 02/27/2026 |
| Keel Paul A | BUY | +115,320 | $29.59 | 02/25/2026 | 02/27/2026 |
| Keel Paul A | BUY | +132,885 | Not reported | 02/25/2026 | 02/27/2026 |
| Keel Paul A | SELL | -11,840 | $29.59 | 02/25/2026 | 02/27/2026 |
| Kaabi Faez C | SELL | -4,964 | $29.59 | 02/25/2026 | 02/27/2026 |
| Nance Mark E | BUY | +23,070 | Not reported | 02/25/2026 | 02/27/2026 |
| Nance Mark E | BUY | +30,040 | $29.59 | 02/25/2026 | 02/27/2026 |
| Nance Mark E | SELL | -3,368 | $29.59 | 02/25/2026 | 02/27/2026 |
| Reis Mischa | BUY | +10,770 | Not reported | 02/25/2026 | 02/27/2026 |
| Reis Mischa | BUY | +14,020 | $29.59 | 02/25/2026 | 02/27/2026 |